文献速递中药与中成药合理使用中医内科

覆盆子民族药理学批判性综述:民族植物学、炮制、化学成分、药理与质量控制

Ethnopharmacology of Rubus idaeus Linnaeus: A critical review on ethnobotany, processing methods, phytochemicals, pharmacology and quality control.
PubMed 文献 · J Ethnopharmacol · 2022-10-29

本文系统综述覆盆子(Rubus idaeus)的民族植物学、炮制方法、化学成分、药理活性与质量控制研究,检索1981至2022年文献。已分离约194种化合物,以酚类、萜类、生物碱、甾体和脂肪酸为主,药理研究涉及降糖调脂、抗阿尔茨海默病、抗骨质疏松、保肝、抗癌、神经保护、抗菌和护肤等,但多数研究未关联传统功效,且高剂量组才能达到相应药效,毒理学与药代动力学研究有限。

要点

  • 覆盆子已分离约194种化合物,富含酚类、萜类、生物碱、甾体和脂肪酸
  • 药理活性广泛,但多数研究未关联传统功效如缩尿、明目
  • 许多药理实验仅高剂量组有效,毒理学与药代动力学研究有限

核心结论

  • 覆盆子的有效性已通过长期临床应用证明,但其药理活性与特定化合物关系尚未阐明。
  • 许多药理实验仅高剂量组能达到相应药效,覆盆子功效需进一步验证。
  • 涉及毒理学和药代动力学的研究非常有限,了解生物利用度和毒理行为有助于理解其药效与安全性。

研究设计与样本

  • 通过Web of Science、PubMed、CNKI和万方数据库检索1981至2022年文献,并查阅相关教材和数字文档进行综述。

主要发现

  • 从覆盆子中分离出约194种化合物,富含酚类、萜类、生物碱、甾体和脂肪酸。
  • 覆盆子具有降糖调脂、抗阿尔茨海默病、抗骨质疏松、保肝、抗癌、神经保护、抗菌和护肤等多种药理活性。
  • 多数研究未关联传统功效如减少排尿和治疗角膜混浊。
  • 许多药理实验中仅高剂量组能达到相应药效。
  • 药理活性与覆盆子特定化合物之间的关系尚未阐明。

临床怎么用

  • 临床应用覆盆子时需关注其传统功效与现代药理研究的关联性不足。
  • 高剂量药理实验结果外推至临床需谨慎,注意剂量与药效关系。
  • 关注覆盆子生物利用度和毒理学行为,以评估其药效与安全性。

局限性

  • 多数药理研究未关联传统功效。
  • 许多药理实验仅高剂量组有效,药效需进一步验证。
  • 药理活性与特定化合物关系尚未阐明。
  • 毒理学和药代动力学研究非常有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Rubus idaeus Linnaeus (RI) is a Chinese herbal medicine that has been widely used in China for a long time to reinforce the kidney, nourish the liver, improve vision, and arrest polyuria. AIM OF THE STUDY: This work aims to evaluate the recent progress of the chemical composition, pharmacological activity, pharmacokinetics, metabolism, and quality control and of Rubus idaeus, which focuses on the insufficiency of existing research and will shed light on future studies of Rubus idaeus. METHODS: Literatures about "Rubus idaeus","Red raspberry" and "Fupenzi"are retrieved by browsing the database, such as Web of Science (http://www.webofknowledge.com/wos), Pubmed (https://pubmed.ncbi.nlm.nih.gov/), CNKI (http://www.cnki.net/), and Wanfang Data (http://www.wanfangdata.com.cn). In addition, related textbooks and digital documents are interrogated to provide a holistic and critical review of the topic. The period of the literature covered from 1981 to 2022. RESULTS: Approximately 194 compounds have been isolated from Rubus idaeus, which is rich in phenols, terpenoids, alkaloids, steroids, and fatty acids. Numerous investigations have demonstrated that Rubus idaeus exhibits many pharmacological activities, including hypoglycemic and hypolipidemic, anti-Alzheimer effect, anti-osteoporosis, hepatoprotective, anti-cancer, neuroprotective, anti-bacteria and skin care, etc. However, it is worth noting that most of the research is not associated with the conventional effect, such as reducing urination and treating opacity of the cornea. CONCLUSION: The effectiveness of Rubus idaeus has been proved by its long-term clinical application. The research on the pharmacological activity of Rubus idaeus has flourished. In many pharmacological experiments, only the high-dose group can achieve the corresponding efficacy, so the efficacy of Rubus idaeus needs to be further interrogated. Meanwhile, the relationship between pharmacological activity and specific compounds of Rubus idaeus has not been clarified yet. Last but not least, studies involving toxicology and pharmacokinetics are very limited. Knowledge of bioavailability and toxicological behavior of Rubus idaeus can help understand the herb's pharmacodynamic and safety profile.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Tao Y, Bao J, Zhu F, et al. Ethnopharmacology of Rubus idaeus Linnaeus: A critical review on ethnobotany, processing methods, phytochemicals, pharmacology and quality control. J Ethnopharmacol. 2022. PMID: 36341819. doi:10.1016/j.jep.2022.115870

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。